martes, 6 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleCrunchbase News

Exclusive: From Booking Calls To Late Check-Ins, Dextr AI Raises $6.7M For Hotel AI Agents

View original at news.crunchbase.com
Crunchbase News - Funding Ma Title: Exclusive: From Booking Calls To Late Check-Ins, Dextr AI Raises $6.7M For Hotel AI Agents Date: 2026-09-24 13:00 Source: https://news.crunchbase.com/venture/dextr-ai-hospitality-agents-raises-seed-funding/ <p>When <a href="https://www.crunchbase.com/person/sajid-shariff">Sajid Shari…
Opening lines of the source · Crunchbase News · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Sajid and Scott's execution stood out; Dextr scaled to hundreds of contracted properties and meaningful ARR without raising a single dollar prior to this round

    60% confidence
  • It was very hard to hire for overnight front desk shifts

    60% confidence
  • Online reviews improved at both initial properties within 90 days of deploying the Alfred agent

    60% confidence
  • Connecting multiple agent use cases is important to achieving higher ROI for hotel properties

    60% confidence
  • Dextr's agents now handle more than 1 million interactions a month across hundreds of hotels

    60% confidence
  • Dextr's annual recurring revenue has been growing about 20% to 30% month over month

    60% confidence
  • Staffing an overnight front desk shift could cost a property $70,000 to $80,000 a year in a market such as California

    60% confidence
  • In a space where most AI companies are still searching for product-market fit, Dextr had customers, zero churn, and a clear ROI story, which matches what Elevation Capital looks for

    60% confidence
  • One large hotel that Dextr works with handles $100,000 to $300,000 a month in bookings through the voice agent Daisy

    60% confidence

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com